nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrapone—Niacin—coronary artery disease	0.402	1	CrCtD
Metyrapone—Etofibrate—Fenofibrate—coronary artery disease	0.202	1	CrCrCtD
Metyrapone—CYP11B2—coronary artery disease	0.176	1	CbGaD
Metyrapone—CYP11B2—Eplerenone—coronary artery disease	0.0973	0.613	CbGbCtD
Metyrapone—ABCC3—Ezetimibe—coronary artery disease	0.0244	0.153	CbGbCtD
Metyrapone—CYP3A4—Ticagrelor—coronary artery disease	0.00543	0.0342	CbGbCtD
Metyrapone—CYP3A4—Fenofibrate—coronary artery disease	0.00484	0.0305	CbGbCtD
Metyrapone—CYP3A4—Gemfibrozil—coronary artery disease	0.00387	0.0244	CbGbCtD
Metyrapone—CYP3A4—Clopidogrel—coronary artery disease	0.00336	0.0211	CbGbCtD
Metyrapone—CYP3A4—Eplerenone—coronary artery disease	0.00312	0.0196	CbGbCtD
Metyrapone—CYP3A4—Enalapril—coronary artery disease	0.00278	0.0175	CbGbCtD
Metyrapone—CYP3A4—Ezetimibe—coronary artery disease	0.00216	0.0136	CbGbCtD
Metyrapone—CYP3A4—Rosuvastatin—coronary artery disease	0.00216	0.0136	CbGbCtD
Metyrapone—CYP3A4—Simvastatin—coronary artery disease	0.00201	0.0127	CbGbCtD
Metyrapone—CYP3A4—Lovastatin—coronary artery disease	0.00197	0.0124	CbGbCtD
Metyrapone—CYP3A4—Pravastatin—coronary artery disease	0.00197	0.0124	CbGbCtD
Metyrapone—CYP3A4—Atorvastatin—coronary artery disease	0.00179	0.0113	CbGbCtD
Metyrapone—CYP3A4—Losartan—coronary artery disease	0.00164	0.0103	CbGbCtD
Metyrapone—Angiopathy—Trandolapril—coronary artery disease	0.000119	0.00357	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Clopidogrel—coronary artery disease	0.000118	0.00355	CcSEcCtD
Metyrapone—Dizziness—Penbutolol—coronary artery disease	0.000118	0.00354	CcSEcCtD
Metyrapone—Hypertension—Ezetimibe—coronary artery disease	0.000117	0.00353	CcSEcCtD
Metyrapone—Abdominal pain—Ticagrelor—coronary artery disease	0.000117	0.00353	CcSEcCtD
Metyrapone—Abdominal discomfort—Ramipril—coronary artery disease	0.000117	0.00352	CcSEcCtD
Metyrapone—Angiopathy—Telmisartan—coronary artery disease	0.000117	0.00351	CcSEcCtD
Metyrapone—Pancytopenia—Ramipril—coronary artery disease	0.000116	0.00348	CcSEcCtD
Metyrapone—Alopecia—Trandolapril—coronary artery disease	0.000116	0.00348	CcSEcCtD
Metyrapone—Alopecia—Enalapril—coronary artery disease	0.000115	0.00346	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—coronary artery disease	0.000115	0.00346	CcSEcCtD
Metyrapone—Pain—Rosuvastatin—coronary artery disease	0.000114	0.00344	CcSEcCtD
Metyrapone—Nervous system disorder—Fenofibrate—coronary artery disease	0.000114	0.00342	CcSEcCtD
Metyrapone—Skin disorder—Fenofibrate—coronary artery disease	0.000112	0.00339	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Eplerenone—coronary artery disease	0.000112	0.00339	CcSEcCtD
Metyrapone—Nervous system disorder—Clopidogrel—coronary artery disease	0.000112	0.00336	CcSEcCtD
Metyrapone—Headache—Penbutolol—coronary artery disease	0.000111	0.00336	CcSEcCtD
Metyrapone—Skin disorder—Clopidogrel—coronary artery disease	0.000111	0.00333	CcSEcCtD
Metyrapone—Alopecia—Captopril—coronary artery disease	0.00011	0.00332	CcSEcCtD
Metyrapone—Angiopathy—Perindopril—coronary artery disease	0.00011	0.00331	CcSEcCtD
Metyrapone—Gastrointestinal pain—Rosuvastatin—coronary artery disease	0.000109	0.00329	CcSEcCtD
Metyrapone—Nervous system disorder—Ezetimibe—coronary artery disease	0.000109	0.00328	CcSEcCtD
Metyrapone—Hypotension—Fenofibrate—coronary artery disease	0.000108	0.00326	CcSEcCtD
Metyrapone—Skin disorder—Ezetimibe—coronary artery disease	0.000108	0.00324	CcSEcCtD
Metyrapone—Alopecia—Perindopril—coronary artery disease	0.000107	0.00323	CcSEcCtD
Metyrapone—Angiopathy—Furosemide—coronary artery disease	0.000107	0.00322	CcSEcCtD
Metyrapone—Nervous system disorder—Eplerenone—coronary artery disease	0.000106	0.00321	CcSEcCtD
Metyrapone—Hypotension—Clopidogrel—coronary artery disease	0.000106	0.0032	CcSEcCtD
Metyrapone—Nausea—Penbutolol—coronary artery disease	0.000106	0.00318	CcSEcCtD
Metyrapone—Abdominal pain—Rosuvastatin—coronary artery disease	0.000105	0.00318	CcSEcCtD
Metyrapone—Skin disorder—Eplerenone—coronary artery disease	0.000105	0.00318	CcSEcCtD
Metyrapone—Pancytopenia—Lisinopril—coronary artery disease	0.000105	0.00316	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Valsartan—coronary artery disease	0.000103	0.00312	CcSEcCtD
Metyrapone—Angiopathy—Losartan—coronary artery disease	0.000103	0.00311	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Olmesartan—coronary artery disease	0.000103	0.0031	CcSEcCtD
Metyrapone—Hypotension—Eplerenone—coronary artery disease	0.000101	0.00306	CcSEcCtD
Metyrapone—Hypertension—Pravastatin—coronary artery disease	0.000101	0.00305	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Niacin—coronary artery disease	0.000101	0.00303	CcSEcCtD
Metyrapone—Alopecia—Losartan—coronary artery disease	0.0001	0.00303	CcSEcCtD
Metyrapone—Dizziness—Gemfibrozil—coronary artery disease	0.0001	0.00302	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Fenofibrate—coronary artery disease	0.0001	0.00301	CcSEcCtD
Metyrapone—Pain—Fenofibrate—coronary artery disease	9.9e-05	0.00298	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Clopidogrel—coronary artery disease	9.83e-05	0.00296	CcSEcCtD
Metyrapone—Dizziness—Ticagrelor—coronary artery disease	9.8e-05	0.00295	CcSEcCtD
Metyrapone—Nervous system disorder—Valsartan—coronary artery disease	9.8e-05	0.00295	CcSEcCtD
Metyrapone—Nervous system disorder—Olmesartan—coronary artery disease	9.75e-05	0.00294	CcSEcCtD
Metyrapone—Pain—Clopidogrel—coronary artery disease	9.74e-05	0.00293	CcSEcCtD
Metyrapone—Skin disorder—Valsartan—coronary artery disease	9.7e-05	0.00292	CcSEcCtD
Metyrapone—Pain—Lovastatin—coronary artery disease	9.67e-05	0.00291	CcSEcCtD
Metyrapone—Skin disorder—Olmesartan—coronary artery disease	9.66e-05	0.00291	CcSEcCtD
Metyrapone—Hypertension—Telmisartan—coronary artery disease	9.65e-05	0.00291	CcSEcCtD
Metyrapone—Vomiting—Gemfibrozil—coronary artery disease	9.65e-05	0.00291	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Trandolapril—coronary artery disease	9.62e-05	0.0029	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Ezetimibe—coronary artery disease	9.58e-05	0.00288	CcSEcCtD
Metyrapone—Headache—Gemfibrozil—coronary artery disease	9.51e-05	0.00286	CcSEcCtD
Metyrapone—Pain—Ezetimibe—coronary artery disease	9.49e-05	0.00286	CcSEcCtD
Metyrapone—Gastrointestinal pain—Fenofibrate—coronary artery disease	9.47e-05	0.00285	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Telmisartan—coronary artery disease	9.45e-05	0.00285	CcSEcCtD
Metyrapone—Skin disorder—Niacin—coronary artery disease	9.43e-05	0.00284	CcSEcCtD
Metyrapone—Vomiting—Ticagrelor—coronary artery disease	9.43e-05	0.00284	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Eplerenone—coronary artery disease	9.37e-05	0.00282	CcSEcCtD
Metyrapone—Hypotension—Valsartan—coronary artery disease	9.33e-05	0.00281	CcSEcCtD
Metyrapone—Gastrointestinal pain—Clopidogrel—coronary artery disease	9.31e-05	0.0028	CcSEcCtD
Metyrapone—Hypotension—Olmesartan—coronary artery disease	9.29e-05	0.0028	CcSEcCtD
Metyrapone—Headache—Ticagrelor—coronary artery disease	9.29e-05	0.0028	CcSEcCtD
Metyrapone—Pain—Eplerenone—coronary artery disease	9.28e-05	0.0028	CcSEcCtD
Metyrapone—Gastrointestinal pain—Lovastatin—coronary artery disease	9.25e-05	0.00278	CcSEcCtD
Metyrapone—Abdominal pain—Fenofibrate—coronary artery disease	9.16e-05	0.00276	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Simvastatin—coronary artery disease	9.13e-05	0.00275	CcSEcCtD
Metyrapone—Hypertension—Perindopril—coronary artery disease	9.11e-05	0.00274	CcSEcCtD
Metyrapone—Nervous system disorder—Trandolapril—coronary artery disease	9.11e-05	0.00274	CcSEcCtD
Metyrapone—Hypotension—Niacin—coronary artery disease	9.08e-05	0.00273	CcSEcCtD
Metyrapone—Gastrointestinal pain—Ezetimibe—coronary artery disease	9.07e-05	0.00273	CcSEcCtD
Metyrapone—Pain—Simvastatin—coronary artery disease	9.05e-05	0.00272	CcSEcCtD
Metyrapone—Skin disorder—Trandolapril—coronary artery disease	9.02e-05	0.00272	CcSEcCtD
Metyrapone—Nausea—Gemfibrozil—coronary artery disease	9.01e-05	0.00271	CcSEcCtD
Metyrapone—Abdominal pain—Clopidogrel—coronary artery disease	9e-05	0.00271	CcSEcCtD
Metyrapone—Nervous system disorder—Telmisartan—coronary artery disease	8.95e-05	0.00269	CcSEcCtD
Metyrapone—Abdominal pain—Lovastatin—coronary artery disease	8.94e-05	0.00269	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Perindopril—coronary artery disease	8.92e-05	0.00269	CcSEcCtD
Metyrapone—Gastrointestinal pain—Eplerenone—coronary artery disease	8.88e-05	0.00267	CcSEcCtD
Metyrapone—Skin disorder—Telmisartan—coronary artery disease	8.86e-05	0.00267	CcSEcCtD
Metyrapone—Dizziness—Rosuvastatin—coronary artery disease	8.82e-05	0.00266	CcSEcCtD
Metyrapone—Nausea—Ticagrelor—coronary artery disease	8.81e-05	0.00265	CcSEcCtD
Metyrapone—Abdominal pain—Ezetimibe—coronary artery disease	8.77e-05	0.00264	CcSEcCtD
Metyrapone—Hypotension—Trandolapril—coronary artery disease	8.68e-05	0.00261	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Furosemide—coronary artery disease	8.67e-05	0.00261	CcSEcCtD
Metyrapone—Gastrointestinal pain—Simvastatin—coronary artery disease	8.65e-05	0.0026	CcSEcCtD
Metyrapone—Angiopathy—Timolol—coronary artery disease	8.65e-05	0.0026	CcSEcCtD
Metyrapone—Hypotension—Enalapril—coronary artery disease	8.64e-05	0.0026	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Valsartan—coronary artery disease	8.62e-05	0.0026	CcSEcCtD
Metyrapone—Alopecia—Ramipril—coronary artery disease	8.62e-05	0.00259	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Olmesartan—coronary artery disease	8.58e-05	0.00258	CcSEcCtD
Metyrapone—Abdominal pain—Eplerenone—coronary artery disease	8.58e-05	0.00258	CcSEcCtD
Metyrapone—Dizziness—Acetylsalicylic acid—coronary artery disease	8.57e-05	0.00258	CcSEcCtD
Metyrapone—Hypotension—Telmisartan—coronary artery disease	8.53e-05	0.00257	CcSEcCtD
Metyrapone—Pain—Olmesartan—coronary artery disease	8.5e-05	0.00256	CcSEcCtD
Metyrapone—Nervous system disorder—Perindopril—coronary artery disease	8.45e-05	0.00254	CcSEcCtD
Metyrapone—Alopecia—Timolol—coronary artery disease	8.42e-05	0.00254	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Niacin—coronary artery disease	8.39e-05	0.00253	CcSEcCtD
Metyrapone—Skin disorder—Perindopril—coronary artery disease	8.37e-05	0.00252	CcSEcCtD
Metyrapone—Abdominal pain—Simvastatin—coronary artery disease	8.36e-05	0.00252	CcSEcCtD
Metyrapone—Headache—Rosuvastatin—coronary artery disease	8.36e-05	0.00252	CcSEcCtD
Metyrapone—Pain—Niacin—coronary artery disease	8.31e-05	0.0025	CcSEcCtD
Metyrapone—Hypotension—Captopril—coronary artery disease	8.29e-05	0.0025	CcSEcCtD
Metyrapone—Vomiting—Acetylsalicylic acid—coronary artery disease	8.24e-05	0.00248	CcSEcCtD
Metyrapone—Nervous system disorder—Furosemide—coronary artery disease	8.21e-05	0.00247	CcSEcCtD
Metyrapone—Pain—Pravastatin—coronary artery disease	8.18e-05	0.00246	CcSEcCtD
Metyrapone—Gastrointestinal pain—Valsartan—coronary artery disease	8.17e-05	0.00246	CcSEcCtD
Metyrapone—Skin disorder—Furosemide—coronary artery disease	8.13e-05	0.00245	CcSEcCtD
Metyrapone—Gastrointestinal pain—Olmesartan—coronary artery disease	8.13e-05	0.00245	CcSEcCtD
Metyrapone—Hypotension—Perindopril—coronary artery disease	8.05e-05	0.00242	CcSEcCtD
Metyrapone—Angiopathy—Lisinopril—coronary artery disease	8.02e-05	0.00242	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Trandolapril—coronary artery disease	8.02e-05	0.00241	CcSEcCtD
Metyrapone—Gastrointestinal pain—Niacin—coronary artery disease	7.94e-05	0.00239	CcSEcCtD
Metyrapone—Nausea—Rosuvastatin—coronary artery disease	7.93e-05	0.00239	CcSEcCtD
Metyrapone—Nervous system disorder—Losartan—coronary artery disease	7.92e-05	0.00239	CcSEcCtD
Metyrapone—Abdominal pain—Valsartan—coronary artery disease	7.9e-05	0.00238	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Telmisartan—coronary artery disease	7.88e-05	0.00237	CcSEcCtD
Metyrapone—Abdominal pain—Olmesartan—coronary artery disease	7.86e-05	0.00237	CcSEcCtD
Metyrapone—Hypotension—Furosemide—coronary artery disease	7.82e-05	0.00236	CcSEcCtD
Metyrapone—Gastrointestinal pain—Pravastatin—coronary artery disease	7.82e-05	0.00236	CcSEcCtD
Metyrapone—Alopecia—Lisinopril—coronary artery disease	7.81e-05	0.00235	CcSEcCtD
Metyrapone—Pain—Telmisartan—coronary artery disease	7.8e-05	0.00235	CcSEcCtD
Metyrapone—Nausea—Acetylsalicylic acid—coronary artery disease	7.7e-05	0.00232	CcSEcCtD
Metyrapone—Abdominal pain—Niacin—coronary artery disease	7.68e-05	0.00231	CcSEcCtD
Metyrapone—Dizziness—Fenofibrate—coronary artery disease	7.66e-05	0.00231	CcSEcCtD
Metyrapone—Gastrointestinal pain—Trandolapril—coronary artery disease	7.59e-05	0.00229	CcSEcCtD
Metyrapone—Gastrointestinal pain—Enalapril—coronary artery disease	7.56e-05	0.00228	CcSEcCtD
Metyrapone—Abdominal pain—Pravastatin—coronary artery disease	7.56e-05	0.00228	CcSEcCtD
Metyrapone—Hypotension—Losartan—coronary artery disease	7.55e-05	0.00227	CcSEcCtD
Metyrapone—Dizziness—Clopidogrel—coronary artery disease	7.53e-05	0.00227	CcSEcCtD
Metyrapone—Dizziness—Lovastatin—coronary artery disease	7.48e-05	0.00225	CcSEcCtD
Metyrapone—Gastrointestinal pain—Telmisartan—coronary artery disease	7.46e-05	0.00225	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Perindopril—coronary artery disease	7.44e-05	0.00224	CcSEcCtD
Metyrapone—Pain—Perindopril—coronary artery disease	7.37e-05	0.00222	CcSEcCtD
Metyrapone—Vomiting—Fenofibrate—coronary artery disease	7.36e-05	0.00222	CcSEcCtD
Metyrapone—Abdominal pain—Trandolapril—coronary artery disease	7.34e-05	0.00221	CcSEcCtD
Metyrapone—Dizziness—Ezetimibe—coronary artery disease	7.33e-05	0.00221	CcSEcCtD
Metyrapone—Abdominal pain—Enalapril—coronary artery disease	7.31e-05	0.0022	CcSEcCtD
Metyrapone—Headache—Fenofibrate—coronary artery disease	7.26e-05	0.00219	CcSEcCtD
Metyrapone—Gastrointestinal pain—Captopril—coronary artery disease	7.25e-05	0.00218	CcSEcCtD
Metyrapone—Vomiting—Clopidogrel—coronary artery disease	7.24e-05	0.00218	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Furosemide—coronary artery disease	7.23e-05	0.00218	CcSEcCtD
Metyrapone—Abdominal pain—Telmisartan—coronary artery disease	7.21e-05	0.00217	CcSEcCtD
Metyrapone—Vomiting—Lovastatin—coronary artery disease	7.19e-05	0.00217	CcSEcCtD
Metyrapone—Dizziness—Eplerenone—coronary artery disease	7.18e-05	0.00216	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	7.18e-05	0.00216	CcSEcCtD
Metyrapone—Hypertension—Timolol—coronary artery disease	7.16e-05	0.00216	CcSEcCtD
Metyrapone—Pain—Furosemide—coronary artery disease	7.16e-05	0.00216	CcSEcCtD
Metyrapone—Headache—Clopidogrel—coronary artery disease	7.13e-05	0.00215	CcSEcCtD
Metyrapone—Headache—Lovastatin—coronary artery disease	7.08e-05	0.00213	CcSEcCtD
Metyrapone—Vomiting—Ezetimibe—coronary artery disease	7.05e-05	0.00212	CcSEcCtD
Metyrapone—Gastrointestinal pain—Perindopril—coronary artery disease	7.04e-05	0.00212	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	7.02e-05	0.00211	CcSEcCtD
Metyrapone—Abdominal pain—Captopril—coronary artery disease	7.01e-05	0.00211	CcSEcCtD
Metyrapone—Dizziness—Simvastatin—coronary artery disease	6.99e-05	0.00211	CcSEcCtD
Metyrapone—Headache—Ezetimibe—coronary artery disease	6.95e-05	0.00209	CcSEcCtD
Metyrapone—Pain—Losartan—coronary artery disease	6.91e-05	0.00208	CcSEcCtD
Metyrapone—Vomiting—Eplerenone—coronary artery disease	6.9e-05	0.00208	CcSEcCtD
Metyrapone—Nausea—Fenofibrate—coronary artery disease	6.88e-05	0.00207	CcSEcCtD
Metyrapone—Gastrointestinal pain—Furosemide—coronary artery disease	6.85e-05	0.00206	CcSEcCtD
Metyrapone—Abdominal pain—Perindopril—coronary artery disease	6.81e-05	0.00205	CcSEcCtD
Metyrapone—Headache—Eplerenone—coronary artery disease	6.8e-05	0.00205	CcSEcCtD
Metyrapone—Nervous system disorder—Ramipril—coronary artery disease	6.79e-05	0.00205	CcSEcCtD
Metyrapone—Nausea—Clopidogrel—coronary artery disease	6.76e-05	0.00204	CcSEcCtD
Metyrapone—Skin disorder—Ramipril—coronary artery disease	6.73e-05	0.00203	CcSEcCtD
Metyrapone—Vomiting—Simvastatin—coronary artery disease	6.73e-05	0.00203	CcSEcCtD
Metyrapone—Nausea—Lovastatin—coronary artery disease	6.72e-05	0.00202	CcSEcCtD
Metyrapone—Nervous system disorder—Timolol—coronary artery disease	6.64e-05	0.002	CcSEcCtD
Metyrapone—Headache—Simvastatin—coronary artery disease	6.63e-05	0.002	CcSEcCtD
Metyrapone—Abdominal pain—Furosemide—coronary artery disease	6.62e-05	0.00199	CcSEcCtD
Metyrapone—Gastrointestinal pain—Losartan—coronary artery disease	6.61e-05	0.00199	CcSEcCtD
Metyrapone—Dizziness—Valsartan—coronary artery disease	6.61e-05	0.00199	CcSEcCtD
Metyrapone—Nausea—Ezetimibe—coronary artery disease	6.59e-05	0.00198	CcSEcCtD
Metyrapone—Skin disorder—Timolol—coronary artery disease	6.58e-05	0.00198	CcSEcCtD
Metyrapone—Dizziness—Olmesartan—coronary artery disease	6.57e-05	0.00198	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	6.51e-05	0.00196	CcSEcCtD
Metyrapone—Hypotension—Ramipril—coronary artery disease	6.47e-05	0.00195	CcSEcCtD
Metyrapone—Nausea—Eplerenone—coronary artery disease	6.45e-05	0.00194	CcSEcCtD
Metyrapone—Dizziness—Niacin—coronary artery disease	6.42e-05	0.00193	CcSEcCtD
Metyrapone—Abdominal pain—Losartan—coronary artery disease	6.39e-05	0.00192	CcSEcCtD
Metyrapone—Vomiting—Valsartan—coronary artery disease	6.35e-05	0.00191	CcSEcCtD
Metyrapone—Hypotension—Timolol—coronary artery disease	6.33e-05	0.00191	CcSEcCtD
Metyrapone—Dizziness—Pravastatin—coronary artery disease	6.32e-05	0.0019	CcSEcCtD
Metyrapone—Vomiting—Olmesartan—coronary artery disease	6.32e-05	0.0019	CcSEcCtD
Metyrapone—Nausea—Simvastatin—coronary artery disease	6.28e-05	0.00189	CcSEcCtD
Metyrapone—Headache—Valsartan—coronary artery disease	6.26e-05	0.00188	CcSEcCtD
Metyrapone—Headache—Olmesartan—coronary artery disease	6.23e-05	0.00188	CcSEcCtD
Metyrapone—Vomiting—Niacin—coronary artery disease	6.18e-05	0.00186	CcSEcCtD
Metyrapone—Dizziness—Trandolapril—coronary artery disease	6.14e-05	0.00185	CcSEcCtD
Metyrapone—Dizziness—Enalapril—coronary artery disease	6.12e-05	0.00184	CcSEcCtD
Metyrapone—Skin disorder—Lisinopril—coronary artery disease	6.1e-05	0.00184	CcSEcCtD
Metyrapone—Headache—Niacin—coronary artery disease	6.08e-05	0.00183	CcSEcCtD
Metyrapone—Vomiting—Pravastatin—coronary artery disease	6.08e-05	0.00183	CcSEcCtD
Metyrapone—Dizziness—Telmisartan—coronary artery disease	6.03e-05	0.00182	CcSEcCtD
Metyrapone—Headache—Pravastatin—coronary artery disease	5.99e-05	0.0018	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Ramipril—coronary artery disease	5.98e-05	0.0018	CcSEcCtD
Metyrapone—Nausea—Valsartan—coronary artery disease	5.93e-05	0.00179	CcSEcCtD
Metyrapone—Nausea—Olmesartan—coronary artery disease	5.91e-05	0.00178	CcSEcCtD
Metyrapone—Vomiting—Trandolapril—coronary artery disease	5.9e-05	0.00178	CcSEcCtD
Metyrapone—Vomiting—Enalapril—coronary artery disease	5.88e-05	0.00177	CcSEcCtD
Metyrapone—Hypotension—Lisinopril—coronary artery disease	5.87e-05	0.00177	CcSEcCtD
Metyrapone—Dizziness—Captopril—coronary artery disease	5.87e-05	0.00177	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Timolol—coronary artery disease	5.85e-05	0.00176	CcSEcCtD
Metyrapone—Headache—Trandolapril—coronary artery disease	5.82e-05	0.00175	CcSEcCtD
Metyrapone—Vomiting—Telmisartan—coronary artery disease	5.8e-05	0.00175	CcSEcCtD
Metyrapone—Headache—Enalapril—coronary artery disease	5.79e-05	0.00175	CcSEcCtD
Metyrapone—Pain—Timolol—coronary artery disease	5.79e-05	0.00174	CcSEcCtD
Metyrapone—Nausea—Niacin—coronary artery disease	5.77e-05	0.00174	CcSEcCtD
Metyrapone—Headache—Telmisartan—coronary artery disease	5.72e-05	0.00172	CcSEcCtD
Metyrapone—Dizziness—Perindopril—coronary artery disease	5.7e-05	0.00172	CcSEcCtD
Metyrapone—Nausea—Pravastatin—coronary artery disease	5.68e-05	0.00171	CcSEcCtD
Metyrapone—Gastrointestinal pain—Ramipril—coronary artery disease	5.66e-05	0.00171	CcSEcCtD
Metyrapone—Vomiting—Captopril—coronary artery disease	5.64e-05	0.0017	CcSEcCtD
Metyrapone—Headache—Captopril—coronary artery disease	5.56e-05	0.00167	CcSEcCtD
Metyrapone—Gastrointestinal pain—Timolol—coronary artery disease	5.54e-05	0.00167	CcSEcCtD
Metyrapone—Dizziness—Furosemide—coronary artery disease	5.54e-05	0.00167	CcSEcCtD
Metyrapone—Nausea—Trandolapril—coronary artery disease	5.52e-05	0.00166	CcSEcCtD
Metyrapone—Nausea—Enalapril—coronary artery disease	5.49e-05	0.00165	CcSEcCtD
Metyrapone—Vomiting—Perindopril—coronary artery disease	5.48e-05	0.00165	CcSEcCtD
Metyrapone—Abdominal pain—Ramipril—coronary artery disease	5.48e-05	0.00165	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Lisinopril—coronary artery disease	5.42e-05	0.00163	CcSEcCtD
Metyrapone—Nausea—Telmisartan—coronary artery disease	5.42e-05	0.00163	CcSEcCtD
Metyrapone—Headache—Perindopril—coronary artery disease	5.4e-05	0.00163	CcSEcCtD
Metyrapone—Pain—Lisinopril—coronary artery disease	5.37e-05	0.00162	CcSEcCtD
Metyrapone—Abdominal pain—Timolol—coronary artery disease	5.35e-05	0.00161	CcSEcCtD
Metyrapone—Dizziness—Losartan—coronary artery disease	5.34e-05	0.00161	CcSEcCtD
Metyrapone—Vomiting—Furosemide—coronary artery disease	5.32e-05	0.0016	CcSEcCtD
Metyrapone—Nausea—Captopril—coronary artery disease	5.27e-05	0.00159	CcSEcCtD
Metyrapone—Headache—Furosemide—coronary artery disease	5.25e-05	0.00158	CcSEcCtD
Metyrapone—Gastrointestinal pain—Lisinopril—coronary artery disease	5.14e-05	0.00155	CcSEcCtD
Metyrapone—Vomiting—Losartan—coronary artery disease	5.14e-05	0.00155	CcSEcCtD
Metyrapone—Nausea—Perindopril—coronary artery disease	5.12e-05	0.00154	CcSEcCtD
Metyrapone—Headache—Losartan—coronary artery disease	5.06e-05	0.00152	CcSEcCtD
Metyrapone—Nausea—Furosemide—coronary artery disease	4.97e-05	0.0015	CcSEcCtD
Metyrapone—Abdominal pain—Lisinopril—coronary artery disease	4.97e-05	0.0015	CcSEcCtD
Metyrapone—Nausea—Losartan—coronary artery disease	4.8e-05	0.00145	CcSEcCtD
Metyrapone—Dizziness—Ramipril—coronary artery disease	4.58e-05	0.00138	CcSEcCtD
Metyrapone—Dizziness—Timolol—coronary artery disease	4.48e-05	0.00135	CcSEcCtD
Metyrapone—Vomiting—Ramipril—coronary artery disease	4.4e-05	0.00133	CcSEcCtD
Metyrapone—Headache—Ramipril—coronary artery disease	4.34e-05	0.00131	CcSEcCtD
Metyrapone—Vomiting—Timolol—coronary artery disease	4.31e-05	0.0013	CcSEcCtD
Metyrapone—Headache—Timolol—coronary artery disease	4.24e-05	0.00128	CcSEcCtD
Metyrapone—Dizziness—Lisinopril—coronary artery disease	4.15e-05	0.00125	CcSEcCtD
Metyrapone—Nausea—Ramipril—coronary artery disease	4.11e-05	0.00124	CcSEcCtD
Metyrapone—Nausea—Timolol—coronary artery disease	4.02e-05	0.00121	CcSEcCtD
Metyrapone—Vomiting—Lisinopril—coronary artery disease	3.99e-05	0.0012	CcSEcCtD
Metyrapone—Headache—Lisinopril—coronary artery disease	3.94e-05	0.00119	CcSEcCtD
Metyrapone—Nausea—Lisinopril—coronary artery disease	3.73e-05	0.00112	CcSEcCtD
Metyrapone—CYP11B2—Metabolism—PPARG—coronary artery disease	3.78e-06	0.000136	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—APOE—coronary artery disease	3.74e-06	0.000134	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—TXNRD1—coronary artery disease	3.74e-06	0.000134	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CYP11B2—coronary artery disease	3.74e-06	0.000134	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—POMC—coronary artery disease	3.73e-06	0.000134	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—APOA1—coronary artery disease	3.7e-06	0.000133	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SLC22A3—coronary artery disease	3.68e-06	0.000132	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—HADH—coronary artery disease	3.63e-06	0.00013	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ARNTL—coronary artery disease	3.63e-06	0.00013	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—VCAN—coronary artery disease	3.62e-06	0.00013	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ALDOA—coronary artery disease	3.59e-06	0.000129	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GSTP1—coronary artery disease	3.57e-06	0.000128	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.54e-06	0.000127	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PPARGC1A—coronary artery disease	3.53e-06	0.000127	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—HMOX1—coronary artery disease	3.52e-06	0.000126	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—DCN—coronary artery disease	3.48e-06	0.000125	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CAT—coronary artery disease	3.47e-06	0.000125	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PLA2G2A—coronary artery disease	3.44e-06	0.000124	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GPX2—coronary artery disease	3.44e-06	0.000124	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—APOA2—coronary artery disease	3.44e-06	0.000124	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—ALB—coronary artery disease	3.4e-06	0.000122	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GPX4—coronary artery disease	3.4e-06	0.000122	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SULT1A1—coronary artery disease	3.4e-06	0.000122	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ABCG5—coronary artery disease	3.4e-06	0.000122	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—HK1—coronary artery disease	3.4e-06	0.000122	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ALDH2—coronary artery disease	3.39e-06	0.000122	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—APOB—coronary artery disease	3.37e-06	0.000121	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—HADHA—coronary artery disease	3.36e-06	0.000121	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	3.36e-06	0.00012	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CKM—coronary artery disease	3.36e-06	0.00012	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PPAP2B—coronary artery disease	3.36e-06	0.00012	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GSTA1—coronary artery disease	3.32e-06	0.000119	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—HBA1—coronary artery disease	3.3e-06	0.000118	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—LIPC—coronary artery disease	3.3e-06	0.000118	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PIK3C2A—coronary artery disease	3.3e-06	0.000118	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CYP2C19—coronary artery disease	3.3e-06	0.000118	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—LPA—coronary artery disease	3.28e-06	0.000118	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—APOC3—coronary artery disease	3.28e-06	0.000118	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GSTM1—coronary artery disease	3.28e-06	0.000118	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PPARG—coronary artery disease	3.26e-06	0.000117	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—LDLR—coronary artery disease	3.26e-06	0.000117	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—NOS3—coronary artery disease	3.25e-06	0.000117	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—SLC9A1—coronary artery disease	3.22e-06	0.000116	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GSTT1—coronary artery disease	3.22e-06	0.000116	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—LPL—coronary artery disease	3.22e-06	0.000115	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—POMC—coronary artery disease	3.22e-06	0.000115	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GCLC—coronary artery disease	3.19e-06	0.000114	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CETP—coronary artery disease	3.19e-06	0.000114	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PLCB3—coronary artery disease	3.18e-06	0.000114	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—SDC1—coronary artery disease	3.15e-06	0.000113	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—APOA5—coronary artery disease	3.15e-06	0.000113	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—GPX1—coronary artery disease	3.14e-06	0.000113	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SULT4A1—coronary artery disease	3.12e-06	0.000112	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CKMT2—coronary artery disease	3.12e-06	0.000112	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PYGM—coronary artery disease	3.12e-06	0.000112	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PDK4—coronary artery disease	3.12e-06	0.000112	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	3.12e-06	0.000112	CbGpPWpGaD
Metyrapone—CYP3A4—Biological oxidations—POMC—coronary artery disease	3.11e-06	0.000112	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—P4HB—coronary artery disease	3.09e-06	0.000111	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—CD36—coronary artery disease	3.06e-06	0.00011	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PLA2G1B—coronary artery disease	3.03e-06	0.000109	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PPP2CA—coronary artery disease	3.02e-06	0.000108	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PTGS2—coronary artery disease	2.98e-06	0.000107	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PSMB5—coronary artery disease	2.98e-06	0.000107	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PSMA6—coronary artery disease	2.98e-06	0.000107	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—ALB—coronary artery disease	2.93e-06	0.000105	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CTGF—coronary artery disease	2.91e-06	0.000104	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—MTHFR—coronary artery disease	2.9e-06	0.000104	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GOT2—coronary artery disease	2.88e-06	0.000103	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—HMGCR—coronary artery disease	2.88e-06	0.000103	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—VCAN—coronary artery disease	2.86e-06	0.000103	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ALDOA—coronary artery disease	2.84e-06	0.000102	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—NOS3—coronary artery disease	2.8e-06	0.000101	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PFKM—coronary artery disease	2.78e-06	9.98e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GK—coronary artery disease	2.78e-06	9.98e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HMGCS2—coronary artery disease	2.78e-06	9.98e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GATM—coronary artery disease	2.78e-06	9.98e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—LDHA—coronary artery disease	2.78e-06	9.98e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GYG1—coronary artery disease	2.78e-06	9.98e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—DCN—coronary artery disease	2.75e-06	9.88e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—AGT—coronary artery disease	2.75e-06	9.87e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—APOE—coronary artery disease	2.7e-06	9.67e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ALDH2—coronary artery disease	2.68e-06	9.61e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—APOA1—coronary artery disease	2.67e-06	9.56e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AK1—coronary artery disease	2.65e-06	9.52e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GCH1—coronary artery disease	2.65e-06	9.52e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PLCB1—coronary artery disease	2.65e-06	9.5e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—HBA1—coronary artery disease	2.61e-06	9.36e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—LIPC—coronary artery disease	2.61e-06	9.36e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CYP2C19—coronary artery disease	2.61e-06	9.36e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PIK3C2A—coronary artery disease	2.61e-06	9.36e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—APOC3—coronary artery disease	2.59e-06	9.3e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—LDLR—coronary artery disease	2.58e-06	9.25e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ABCA1—coronary artery disease	2.57e-06	9.21e-05	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PTGS2—coronary artery disease	2.57e-06	9.21e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	2.55e-06	9.16e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SLC9A1—coronary artery disease	2.55e-06	9.14e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GSTT1—coronary artery disease	2.55e-06	9.14e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—UGCG—coronary artery disease	2.54e-06	9.13e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PPAT—coronary artery disease	2.54e-06	9.13e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—MDH2—coronary artery disease	2.54e-06	9.13e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PLCD1—coronary artery disease	2.54e-06	9.13e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GCLC—coronary artery disease	2.52e-06	9.03e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CETP—coronary artery disease	2.52e-06	9.03e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—SDC1—coronary artery disease	2.49e-06	8.93e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GOT1—coronary artery disease	2.49e-06	8.92e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GGT1—coronary artery disease	2.49e-06	8.92e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PGM1—coronary artery disease	2.45e-06	8.79e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PYGB—coronary artery disease	2.36e-06	8.48e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CKB—coronary artery disease	2.36e-06	8.48e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PSMB5—coronary artery disease	2.35e-06	8.44e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PSMA6—coronary artery disease	2.35e-06	8.44e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PPARG—coronary artery disease	2.35e-06	8.43e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—POMC—coronary artery disease	2.32e-06	8.31e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CTGF—coronary artery disease	2.3e-06	8.24e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GOT2—coronary artery disease	2.28e-06	8.17e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—HMGCR—coronary artery disease	2.28e-06	8.17e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GSTP1—coronary artery disease	2.23e-06	8.01e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PFKFB3—coronary artery disease	2.22e-06	7.98e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—COX5B—coronary artery disease	2.22e-06	7.98e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GSTM2—coronary artery disease	2.22e-06	7.98e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—DLAT—coronary artery disease	2.22e-06	7.98e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PLIN1—coronary artery disease	2.22e-06	7.98e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PPARGC1A—coronary artery disease	2.21e-06	7.94e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—HMOX1—coronary artery disease	2.2e-06	7.9e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CAT—coronary artery disease	2.17e-06	7.8e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—ALB—coronary artery disease	2.11e-06	7.58e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—APOB—coronary artery disease	2.11e-06	7.57e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SULT1E1—coronary artery disease	2.11e-06	7.56e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PLCB1—coronary artery disease	2.09e-06	7.51e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GSTM1—coronary artery disease	2.05e-06	7.37e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ABCA1—coronary artery disease	2.03e-06	7.28e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—NOS3—coronary artery disease	2.02e-06	7.25e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—LPL—coronary artery disease	2.01e-06	7.23e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AKR1B1—coronary artery disease	2.01e-06	7.21e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HK2—coronary artery disease	2.01e-06	7.21e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—GPX1—coronary artery disease	1.97e-06	7.05e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GGT1—coronary artery disease	1.97e-06	7.05e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GOT1—coronary artery disease	1.97e-06	7.05e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SLC27A1—coronary artery disease	1.93e-06	6.92e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—CD36—coronary artery disease	1.91e-06	6.87e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CPT1B—coronary artery disease	1.89e-06	6.78e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PPP2CA—coronary artery disease	1.89e-06	6.78e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—LCAT—coronary artery disease	1.89e-06	6.78e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—APOA4—coronary artery disease	1.86e-06	6.66e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PTGS2—coronary artery disease	1.85e-06	6.63e-05	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—PIK3CA—coronary artery disease	1.83e-06	6.57e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—MTHFR—coronary artery disease	1.81e-06	6.51e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PDHA1—coronary artery disease	1.79e-06	6.43e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GCLM—coronary artery disease	1.79e-06	6.43e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GSTP1—coronary artery disease	1.77e-06	6.33e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PPARGC1A—coronary artery disease	1.75e-06	6.28e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—HMOX1—coronary artery disease	1.74e-06	6.25e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—TXNRD1—coronary artery disease	1.74e-06	6.23e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYP11B2—coronary artery disease	1.74e-06	6.23e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—AGT—coronary artery disease	1.72e-06	6.18e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CAT—coronary artery disease	1.72e-06	6.16e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SLC22A3—coronary artery disease	1.71e-06	6.13e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—APOE—coronary artery disease	1.69e-06	6.06e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.68e-06	6.05e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HADH—coronary artery disease	1.68e-06	6.05e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—APOA1—coronary artery disease	1.67e-06	5.99e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—APOB—coronary artery disease	1.67e-06	5.98e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GSTM1—coronary artery disease	1.62e-06	5.82e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GPX2—coronary artery disease	1.6e-06	5.73e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—APOA2—coronary artery disease	1.6e-06	5.73e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	1.6e-06	5.73e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—LPL—coronary artery disease	1.59e-06	5.71e-05	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—PIK3CA—coronary artery disease	1.58e-06	5.66e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ABCG5—coronary artery disease	1.58e-06	5.66e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GPX4—coronary artery disease	1.58e-06	5.66e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SULT1A1—coronary artery disease	1.58e-06	5.66e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HK1—coronary artery disease	1.58e-06	5.66e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HADHA—coronary artery disease	1.56e-06	5.59e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—GPX1—coronary artery disease	1.55e-06	5.57e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GSTA1—coronary artery disease	1.54e-06	5.53e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—LPA—coronary artery disease	1.52e-06	5.47e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—CD36—coronary artery disease	1.51e-06	5.43e-05	CbGpPWpGaD
Metyrapone—CYP11B2—Metabolism—AKT1—coronary artery disease	1.5e-06	5.37e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PPP2CA—coronary artery disease	1.49e-06	5.36e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PLCB3—coronary artery disease	1.48e-06	5.3e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PPARG—coronary artery disease	1.47e-06	5.28e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—APOA5—coronary artery disease	1.46e-06	5.24e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—POMC—coronary artery disease	1.45e-06	5.21e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—MTHFR—coronary artery disease	1.43e-06	5.14e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—P4HB—coronary artery disease	1.43e-06	5.14e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	1.41e-06	5.05e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—AGT—coronary artery disease	1.36e-06	4.89e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—APOE—coronary artery disease	1.33e-06	4.79e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—VCAN—coronary artery disease	1.33e-06	4.76e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—ALB—coronary artery disease	1.32e-06	4.75e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—APOA1—coronary artery disease	1.32e-06	4.73e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ALDOA—coronary artery disease	1.32e-06	4.72e-05	CbGpPWpGaD
Metyrapone—CYP11B1—Metabolism—AKT1—coronary artery disease	1.29e-06	4.63e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—DCN—coronary artery disease	1.28e-06	4.58e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—NOS3—coronary artery disease	1.27e-06	4.54e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ALDH2—coronary artery disease	1.24e-06	4.46e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	1.21e-06	4.34e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CYP2C19—coronary artery disease	1.21e-06	4.34e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HBA1—coronary artery disease	1.21e-06	4.34e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—LIPC—coronary artery disease	1.21e-06	4.34e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—APOC3—coronary artery disease	1.2e-06	4.32e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—LDLR—coronary artery disease	1.2e-06	4.29e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GSTT1—coronary artery disease	1.18e-06	4.24e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SLC9A1—coronary artery disease	1.18e-06	4.24e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GCLC—coronary artery disease	1.17e-06	4.19e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CETP—coronary artery disease	1.17e-06	4.19e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PPARG—coronary artery disease	1.16e-06	4.17e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PTGS2—coronary artery disease	1.16e-06	4.15e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—SDC1—coronary artery disease	1.15e-06	4.14e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—POMC—coronary artery disease	1.15e-06	4.11e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—PIK3CA—coronary artery disease	1.14e-06	4.08e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PSMA6—coronary artery disease	1.09e-06	3.91e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PSMB5—coronary artery disease	1.09e-06	3.91e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CTGF—coronary artery disease	1.07e-06	3.82e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GOT2—coronary artery disease	1.06e-06	3.79e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HMGCR—coronary artery disease	1.06e-06	3.79e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—ALB—coronary artery disease	1.05e-06	3.75e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—NOS3—coronary artery disease	1e-06	3.59e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PLCB1—coronary artery disease	9.71e-07	3.48e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ABCA1—coronary artery disease	9.41e-07	3.38e-05	CbGpPWpGaD
Metyrapone—ABCC3—Metabolism—AKT1—coronary artery disease	9.28e-07	3.33e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PTGS2—coronary artery disease	9.14e-07	3.28e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GOT1—coronary artery disease	9.12e-07	3.27e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GGT1—coronary artery disease	9.12e-07	3.27e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GSTP1—coronary artery disease	8.19e-07	2.94e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	8.11e-07	2.91e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—HMOX1—coronary artery disease	8.08e-07	2.9e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CAT—coronary artery disease	7.97e-07	2.86e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—APOB—coronary artery disease	7.74e-07	2.78e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GSTM1—coronary artery disease	7.53e-07	2.7e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—LPL—coronary artery disease	7.39e-07	2.65e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—GPX1—coronary artery disease	7.21e-07	2.59e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—PIK3CA—coronary artery disease	7.12e-07	2.55e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—CD36—coronary artery disease	7.02e-07	2.52e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PPP2CA—coronary artery disease	6.93e-07	2.49e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—MTHFR—coronary artery disease	6.65e-07	2.39e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AGT—coronary artery disease	6.32e-07	2.27e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—APOE—coronary artery disease	6.19e-07	2.22e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—APOA1—coronary artery disease	6.12e-07	2.2e-05	CbGpPWpGaD
Metyrapone—CYP2A6—Metabolism—AKT1—coronary artery disease	5.82e-07	2.09e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—PIK3CA—coronary artery disease	5.63e-07	2.02e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PPARG—coronary artery disease	5.39e-07	1.94e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—POMC—coronary artery disease	5.32e-07	1.91e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—ALB—coronary artery disease	4.85e-07	1.74e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—NOS3—coronary artery disease	4.64e-07	1.66e-05	CbGpPWpGaD
Metyrapone—CYP2E1—Metabolism—AKT1—coronary artery disease	4.6e-07	1.65e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PTGS2—coronary artery disease	4.24e-07	1.52e-05	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—PIK3CA—coronary artery disease	2.61e-07	9.37e-06	CbGpPWpGaD
Metyrapone—CYP3A4—Metabolism—AKT1—coronary artery disease	2.13e-07	7.65e-06	CbGpPWpGaD
